Biopharmaceutical News-Q1results-New strategies
Q1 results in Pharma and New strategy to stay in the competition
April 22
Novartis and GSK swap their oncology (valued up to $16 billion) and vaccines business (valued at $ 7.1bn) and form a world-leading consumer healthcare joint-venture between both companies. The deal between Novartis and GSK should be considered as transformational and will undoubtedly impact the European Pharma industry.
At the same time Novartis sells it animal healthcare business to Eli Lilly for $4.5 billion.
April 23
Allergan has adopted a poison pill plan to counter a hostile $47B from Valeant.
Gilead 2014 Q1 net profit more than tripled to $2.2 B boosted by sales of its Hepatitis C pill Sovaldi.
April 24
Novartis 2014 Q1 net profit jumps 24% to $3Bn and beats consensus of$2.7 B mainly boosted by new drugs such as cancer treatment Affinitor and multiple sclerosis pill Gilenya. Sales in emerging market, particularly China all supported the level of earnings.
AstraZeneca misses Earning Per Share (EPS) consensus with flat 2014 Q1 revenues. Core operating profit decrease 11% to $1.95 Bn US
FDA approves Janssen’s Sylvant (siltuximab) to treat patients with a rare disorder Multicentric Castelam’s disease (MCD), the first treatment to be approved for this condition.
April 25
Celgene licences Nogra Pharma Crohn’s drug in a potential $2.6B deal. The drug is expected to enter a late –stage clinical trial by the end of 2014. Under the terms of the deal Nogra will get $710 million upfront and up to $815 million in milestones plus up to $1.05 billion in royalties.
April 27
Merck is supposed to enter negotiations to sell its consumer healthcare business for almost $14B according to a Reuters report.
April 28
Pfizer confirms interest in buying AstraZeneca for as much as $100B. AstraZeneca declined to pursue negotiations.
FDA has granted Roche approval for its human papillomavirus assay to be used as first-line cervical cancer screening for women at least 25 years old.
The European Commission approves GSK Incruse (uneclidinium) as a once-daily bronchodilator in adult patient with chronic obstructive pulmonary disease (COPD). Incruse is a long acting muscarinic antagonist delivered by the Ellipta inhaler.
April 29
Sanofi 2014 Q1 profit rises 9.6% to € 1 .08B but revenue fell 2.6% to €7.48B. Vaccines were down 9.9%, animal health was down 6.7%. Diabetes was up by 13%.
Allergan is preparing a new takeover approach to Sire. This would also help the company in its defense against the hostile acquisition offer from Valeant Pharma.
FDA approves Novartis Zykadia (ceritinib) as treatment for patients with late stage non-small cell lung cancer four months ahead of schedule.
Author : Jean-Claude MULLER, Special Advisor,Innovation & International Relationship (I&IR)
Discover our services in Marketing & Business Development:
See All News
See other Biopharmaceutical News
See other Pharma & Biotech events in 2014
Last News
- US FDA Novel Drug Approval for 2024.
- Note de réflexion de fin d’année
- EMA re-examines its opinion and approves Leqembi for the treatment of Alzheimer’s disease
Events
News archives
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- March 2024
- February 2024
- January 2024
- November 2023
- September 2023
- July 2023
- April 2023
- March 2023
- January 2023
- December 2022
- November 2022
- October 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- October 2018
- June 2018
- May 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- September 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014
- November 2013
- September 2013
- July 2013
- May 2013
- April 2013
- March 2013
- January 2013
- December 2012
- November 2012
- October 2012
- March 2012